跳至主要内容
临床试验/NCT00690170
NCT00690170已完成1 期

Nicotinic Modulation of (NMDA) Receptor Antagonist Schizophrenia-like Information Processing Deficits in Humans

Yale University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2002年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
30
试验地点
1
主要终点
ERP recording procedures: Brain wave activity during tasks involving in processing auditory and visual stimuli with different degrees of attentional and memory demands will be recorded.

研究概览

简要总结

This study examines the interactive effects of ketamine and nicotine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18-50 years old

排除标准

  • 未提供

研究组 & 干预措施

Ketamine and Nicotine

Active Comparator
  • 0.23 mg/kg of ketamine bolus IV (in the arm) over one minute followed by maintenance infusion at 0.58mg/kg/hour x 30 minutes, followed by 0.29 mg/kg/hour x 64 minutes.
  • 13.5 µg/kg of nicotine IV (in the arm) given over 10 min (1.35 µg/min/kg), followed by a constant infusion of 31.02 µg/kg given over 85 min (0.365 µg/min/kg)

干预措施: Ketamine and Nicotine (Drug)

Placebo Comparator

Placebo Comparator

-Placebo administration: Normal saline (sodium chloride 0.9%)over 95 minutes

干预措施: Placebo (Drug)

Ketamine and Placebo

Active Comparator

Ketamine administration: 0.23 mg/kg bolus over one minute followed by maintenance infusion at 0.58mg/kg/hour x 30 minutes, followed by 0.29 mg/kg/hour x 64 minutes

Placebo administration: Normal saline (sodium chloride 0.9%)over 94 minutes

干预措施: Ketamine (Drug)

Nicotine and Placebo

Active Comparator

Nicotine: 13.5 µg/kg given over 10 min (1.35 µg/min/kg)IV (in the arm), followed by a constant infusion of 31.02 µg/kg given over 85 min (0.365 µg/min/kg) Placebo: Normal saline (sodium chloride 0.9%)IV (in the arm)

干预措施: Nicotine (Drug)

结局指标

主要结局

ERP recording procedures: Brain wave activity during tasks involving in processing auditory and visual stimuli with different degrees of attentional and memory demands will be recorded.

时间窗: +65

IntegNeuro is a computerized battery that consists of an automated stimulus presentation to measure cognitive function.

时间窗: +25

Positive and Negative Syndrome Scale will be used to measure psychotic symptoms.

时间窗: -90, +10, +105, +180

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Deepak C. D'Souza

Associate Professor

Yale University

研究点 (1)

Loading locations...

相似试验